Congress created a drug pricing program to deliver affordability. Instead, it’s raising costs

An autoimmune disease diagnosis can mark the start of a difficult medical battle.

But for too many patients, it also marks the beginning of a financial one.

Many of the 50 million Americans living with lupus, rheumatoid arthritis, Crohn’s disease, multiple sclerosis, psoriasis, or other autoimmune diseases rely on expensive therapies and specialty care to […] ...